Tempus Next Pathways unlocked critical insights into the aNSCLC patient journey with Bristol Myers Squibb (BMS)
Discover how BMS collaborated with Tempus to deploy the Next Pathways program across 13 community-based health systems to address care gaps for patients with advanced non-small cell lung cancer (aNSCLC).
Apr 21, 2026
Life Sciences
Case Study


